SURMODICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Director: Gary R. Maharaj

SURMODICS INC.’s own tally for this item (“Elect Director: Gary R. Maharaj”): 8,404,069 for, 187,820 withheld, per its Form 8-K filed February 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 2,869,022 for, 81 withheld, 9,451 abstained.

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

Description as filed by funds: Approve the Merger Agreement, dated as of May 28, 2024, by and among Surmodics, Inc., BCE Parent, LLC, and BCE Merger Sub, Inc., pursuant to which Surmodics, Inc. would be acquired by way of a merger and become a wholly owned subsidiary of BCE Parent, LLC;

SURMODICS INC.’s own tally for this item (“1. The Merger Proposal To adopt and approve the Merger Agreement”): 10,448,258 for, 721,828 against — passed, per its Form 8-K filed August 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 1: The Merger Proposal To adopt and approve the Merger Agreement”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 2,751,214 for.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Set the number of directors at five (5);

SURMODICS INC.’s own tally for this item (“2. Set the Number of Directors”): 10,441,062 for, 59,413 against — passed, per its Form 8-K filed February 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Set the Number of Directors .”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 3,100,899 for.

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

Description as filed by funds: APPROVE ONE OR MORE ADJOURNMENTS OF THE SPECIAL MEETING TO A LATER DATE OR DATES IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO APPROVE THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

SURMODICS INC.’s own tally for this item (“3. The Adjournment Proposal To approve one or more adjournments of the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the Mer”): 10,320,260 for, 778,873 against — passed, per its Form 8-K filed August 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The following votes were cast at the Special Meeting (virtually or by proxy) and the proposal was approved:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 2,447,689 for, 303,525 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Approve, in a non-binding advisory vote, the Company's executive compensation.

SURMODICS INC.’s own tally for this item (“4. Advisory Vote on Executive Compensation”): 7,415,339 for, 1,043,557 against — passed, per its Form 8-K filed February 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved, on an advisory basis, the compensation of the Company's named executive officers by the following vote:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 58 managers: 2,727,516 for, 389,788 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 134 managers: 4,995,697 for, 554,074 against, 102,674 abstained, 124,467 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger; and

SURMODICS INC.’s own tally for this item (“2. The Golden Parachute Proposal To approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger”): 9,081,752 for, 1,980,220 against — passed, per its Form 8-K filed August 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The following votes were cast at the Special Meeting (virtually or by proxy) and the proposal was approved:”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 61 managers: 2,115,278 for, 631,355 against, 4,581 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 131 managers: 6,228,614 for, 1,287,722 against, 28,939 abstained, 1,386 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratify the appointment of Deloitte & Touche LLP as Surmodics' independent registered public accounting firm for fiscal year 2025; and

SURMODICS INC.’s own tally for this item (“3. Ratification of the Appointment of Deloitte & Touche LLP”): 10,463,759 for, 35,348 against — passed, per its Form 8-K filed February 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025 by the following vote:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 3,117,223 for, 81 against.

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.